Shin Nippon Biomedical Laboratories (TSE:2395) Days Sales Outstanding : 81.12 (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Days Sales Outstanding?

Shin Nippon Biomedical Laboratories's average Accounts Receivable for the three months ended in Dec. 2023 was 円5,423 Mil. Shin Nippon Biomedical Laboratories's Revenue for the three months ended in Dec. 2023 was 円6,101 Mil. Hence, Shin Nippon Biomedical Laboratories's Days Sales Outstanding for the three months ended in Dec. 2023 was 81.12.

The historical rank and industry rank for Shin Nippon Biomedical Laboratories's Days Sales Outstanding or its related term are showing as below:

TSE:2395' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.95 Med: 61.59 Max: 77.14
Current: 70.38

During the past 13 years, Shin Nippon Biomedical Laboratories's highest Days Sales Outstanding was 77.14. The lowest was 52.95. And the median was 61.59.

TSE:2395's Days Sales Outstanding is ranked worse than
52.49% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: 69.32 vs TSE:2395: 70.38

Shin Nippon Biomedical Laboratories's Days Sales Outstanding increased from Dec. 2022 (57.18) to Dec. 2023 (81.12).

Shin Nippon Biomedical Laboratories Days Sales Outstanding Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Days Sales Outstanding Chart

Shin Nippon Biomedical Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

57.55

67.14

66.38

60.09

72.72

Shin Nippon Biomedical Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															45.92	69.75	69.80	81.12	61.65

Competitive Comparison of Shin Nippon Biomedical Laboratories's Days Sales Outstanding

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shin Nippon Biomedical Laboratories's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Days Sales Outstanding falls into.

Shin Nippon Biomedical Laboratories Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Shin Nippon Biomedical Laboratories's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (4760.363	+	5778.872)	/	2 )	/	26450.468	*	365
=	5269.6175					/	26450.468	*	365
=	72.72

Shin Nippon Biomedical Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (5186.248	+	5660.479)	/	2 )	/	6100.678	*	365 / 4
=	5423.3635					/	6100.678	*	365 / 4
=	81.12

Shin Nippon Biomedical Laboratories (TSE:2395) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Shin Nippon Biomedical Laboratories Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (TSE:2395) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (TSE:2395) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

YB3:Germany

Address

8-1 Akashi-cho, Tokyo, JPN

Website

http://www.snbl.co.jp

Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (TSE:2395) Headlines

No Headlines